These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1628 related articles for article (PubMed ID: 35314921)

  • 1. Multisystem Inflammatory Syndrome in Children (MIS-C).
    Patel JM
    Curr Allergy Asthma Rep; 2022 May; 22(5):53-60. PubMed ID: 35314921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey.
    Cattalini M; Della Paolera S; Zunica F; Bracaglia C; Giangreco M; Verdoni L; Meini A; Sottile R; Caorsi R; Zuccotti G; Fabi M; Montin D; Meneghel A; Consolaro A; Dellepiane RM; Maggio MC; La Torre F; Marchesi A; Simonini G; Villani A; Cimaz R; Ravelli A; Taddio A;
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):29. PubMed ID: 33726806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment.
    Zhang QY; Xu BW; Du JB
    World J Pediatr; 2021 Aug; 17(4):335-340. PubMed ID: 34013488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2.
    Whittaker E; Bamford A; Kenny J; Kaforou M; Jones CE; Shah P; Ramnarayan P; Fraisse A; Miller O; Davies P; Kucera F; Brierley J; McDougall M; Carter M; Tremoulet A; Shimizu C; Herberg J; Burns JC; Lyall H; Levin M;
    JAMA; 2020 Jul; 324(3):259-269. PubMed ID: 32511692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain.
    García-Salido A; de Carlos Vicente JC; Belda Hofheinz S; Balcells Ramírez J; Slöcker Barrio M; Leóz Gordillo I; Hernández Yuste A; Guitart Pardellans C; Cuervas-Mons Tejedor M; Huidobro Labarga B; Vázquez Martínez JL; Gutiérrez Jimeno M; Oulego-Erróz I; Trastoy Quintela J; Medina Monzón C; Medina Ramos L; Holanda Peña MS; Gil-Antón J; Sorribes Ortí C; Flores González JC; Hernández Palomo RM; Sánchez Ganfornina I; Fernández Romero E; García-Besteiro M; López-Herce Cid J; González Cortés R;
    Crit Care; 2020 Nov; 24(1):666. PubMed ID: 33243303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management.
    Kabeerdoss J; Pilania RK; Karkhele R; Kumar TS; Danda D; Singh S
    Rheumatol Int; 2021 Jan; 41(1):19-32. PubMed ID: 33219837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multisystem inflammatory syndrome in children in the context of coronavirus disease 2019 pandemic].
    Zhou B; Huang YK; Hong SX; Jiao FY; Xie KS
    Zhongguo Dang Dai Er Ke Za Zhi; 2024 Jan; 26(1):98-102. PubMed ID: 38269467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multisystem inflammatory syndrome in children (MIS-C): A nationwide collaborative study in the Greek population.
    Lampidi S; Maritsi D; Charakida M; Eleftheriou I; Farmaki E; Spyridis N; Charisi K; Vantsi P; Filippatos F; Skourti K; Papadopoulou-Alataki E; Papadopoulou-Legbelou K; Kampouridou P; Grivea IN; Vergadi E; Gkentzi D; Dimou D; Koletsi P; Fotis L; Liakopoulou T; Agrafiotou A; Kourtesi K; Tsolas G; Kafetzis D; Papaevangelou V; Dimitriou G; Galanakis E; Syrogiannopoulos GA; Spoulou V; Michos A; Roilides E; Tsolia MN
    Eur J Pediatr; 2024 Apr; 183(4):1693-1702. PubMed ID: 38214810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study.
    Abrams JY; Oster ME; Godfred-Cato SE; Bryant B; Datta SD; Campbell AP; Leung JW; Tsang CA; Pierce TJ; Kennedy JL; Hammett TA; Belay ED
    Lancet Child Adolesc Health; 2021 May; 5(5):323-331. PubMed ID: 33711293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe clinical spectrum with high mortality in pediatric patients with COVID-19 and multisystem inflammatory syndrome.
    Pereira MFB; Litvinov N; Farhat SCL; Eisencraft AP; Gibelli MABC; Carvalho WB; Fernandes VR; Fink TT; Framil JVS; Galleti KV; Fante AL; Fonseca MFM; Watanabe A; Paula CSY; Palandri GG; Leal GN; Diniz MFR; Pinho JRR; Silva CA; Marques HHS; ; Rossi Junior A; Delgado AF; Andrade APM; Schvartsman C; Sabino EC; Rocha MC; Kanunfre KA; Okay TS; Carneiro-Sampaio MMS; Jorge PPD
    Clinics (Sao Paulo); 2020; 75():e2209. PubMed ID: 32844958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multisystem Inflammatory Syndrome in Children.
    Waseem M; Shariff MA; Tay ET; Mortel D; Savadkar S; Lee H; Kondamudi N; Liang T
    J Emerg Med; 2022 Jan; 62(1):28-37. PubMed ID: 34538678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MIS-C among return visits for fever in a pediatric emergency department during the COVID-19 pandemic.
    Kannikeswaran N; Merolla DM; Bond K; Philip L; Sethuraman U
    Am J Emerg Med; 2022 Feb; 52():184-186. PubMed ID: 34942428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children.
    Chen MR; Kuo HC; Lee YJ; Chi H; Li SC; Lee HC; Yang KD
    Front Immunol; 2021; 12():632890. PubMed ID: 33732254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multisystem inflammatory syndrome in children (MIS-C) and neonates (MIS-N) associated with COVID-19: optimizing definition and management.
    Molloy EJ; Nakra N; Gale C; Dimitriades VR; Lakshminrusimha S
    Pediatr Res; 2023 May; 93(6):1499-1508. PubMed ID: 36050390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 7-Year-Old Boy and a 14-Year-Old Girl Initially Diagnosed with Toxic Shock Syndrome and Tested Positive for SARS-CoV-2 Infection, Supporting a Diagnosis of Multisystem Inflammatory Syndrome in Children (MIS-C).
    Giordano S; Failla MC; Li Cavoli MG; Romano D; Vanella V; Caruso C; Chillura I; Maggio MC
    Am J Case Rep; 2021 Oct; 22():e931570. PubMed ID: 34635631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19-Related Multi-systemic Inflammatory Syndrome in Children (MIS-C).
    Henderson LA
    Adv Exp Med Biol; 2024; 1448():409-425. PubMed ID: 39117830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multisystem Inflammatory Syndrome in Children (MIS-C) in a Low-income Country: What Treatment Should be Adopted in Case of a Lack of Immunoglobulin?
    Abdeladim B; Massilia B; Aziza E; Zohair E; Ayad G; Maria R
    Rev Recent Clin Trials; 2024; 19(2):150-157. PubMed ID: 38151848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach.
    Sperotto F; Friedman KG; Son MBF; VanderPluym CJ; Newburger JW; Dionne A
    Eur J Pediatr; 2021 Feb; 180(2):307-322. PubMed ID: 32803422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of early characteristics of multisystemic inflammatory syndrome and Kawasaki disease in children and the course of Kawasaki disease in the pandemic.
    Alkan F; Bircan O; Bal A; Bayturan S; Zengin N; Coskun S
    BMC Pediatr; 2024 Jul; 24(1):485. PubMed ID: 39080588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delineating phenotypes of Kawasaki disease and SARS-CoV-2-related inflammatory multisystem syndrome: a French study and literature review.
    Cherqaoui B; Koné-Paut I; Yager H; Bourgeois FL; Piram M
    Rheumatology (Oxford); 2021 Oct; 60(10):4530-4537. PubMed ID: 33493353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 82.